Metropolis Healthcare Limited

METROPOLIS.NS

METROPOLIS.NSMetropolis Healthcare Limited IN flag

National Stock Exchange of India

1,870.70

INR

+21.15

(+1.14%)

28.80EPS

64.95P/E

95.91BMarket Cap

Jan 31Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

INE112L01020

CUSIP

Y59774110

Return %

Stock

S&P500

18.24

25.76

-26.22

38.63

11.95

83.81

Use logarithmic scale

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	94.41	109.76	129.68	152.22	170.45	196.02	240.11	224.28	235.79	250.89
Basic EPS, GAAP	15.25	20.48	21	24.06	25.36	35.97	41.87	27.91	24.95	28.9
Free Cash Flow per Basic Share	14.83	17.16	16.93	13.3	34.21	43.37	43.52	37.98	39.11	- -
Dividend per Share	16.46	0.06	10.63	13.33	7.99	8.03	8	8	4	- -
Book Value per Share	40.51	49.68	67.46	61.76	76.02	102.43	135.34	154.82	175.38	2
Tangible Book Value per Share	51.2	49.76	67.3	63.7	80.99	114.57	14.11	31.48	50.42	68.42
Basic Weighted Avg Shares	50	50	50	50	50	51	51	51	51	51
Sales/Revenue/Turnover	4,755	5,447	6,436	7,601	8,558	9,978	12,283	11,482	12,077	12,853
Operating Margin (%)	23.71	25.46	25.77	24.59	20.72	24.7	23.51	18.19	16.84	17.51
Depreciation Expense	166	172	190	201	393	459	632	892	945	1,038
Net Income, GAAP	768	1,017	1,042	1,201	1,273	1,831	2,142	1,429	1,278	1,480
Effective Tax Rate (%)	35.73	32.93	31.67	33.74	24.41	24.96	26.82	23.52	26.47	25.64
Profit Margin (%)	16.15	18.66	16.2	15.81	14.88	18.35	17.44	12.44	10.58	11.52
Working Capital	1,344	1,333	2,097	1,802	2,276	4,045	916	378	700	1,527
LT Debt	5	4	2	- -	458	789	2,413	1,541	1,191	1,089
Total Equity	2,939	3,442	4,291	4,200	5,252	7,081	8,882	9,907	10,993	11,874
Return on Invested Capital (%)	- -	28.66	29.81	29.63	28.1	27.84	20.46	12.64	11.72	12.48
Return on Capital (%)	- -	39.13	31.52	34.55	34.31	34.77	26.71	15.26	13.31	72.67
Return on Common Equity (%)	- -	45.12	35.86	37.36	36.9	40.55	35.29	19.24	15.12	1,444.74

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	- -	10.19%	5.18%
Net Income, GAAP	- -	4.58%	-10.54%
Free Cash Flow	- -	35.68%	3.01%
Total Cash Common Dividend	- -	-17.52%	-49.97%
Total Equity	- -	21.57%	10.96%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Surendran Chemmenkotil
Full Time Employees: 4,313
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Address: 250-D, Udyog Bhavan Mumbai India 400030
IPO Date: Apr 15, 2019
Website: metropolisindia.com
Similar Companies: Diagnósticos da América S.A. (DASA3.SA)
Kim Forest Enterprise Co., Ltd. (6645.TW)
Cyclo3pss Corporation (CYPS)
Eurofins Scientific SE (ERF.PA)
Monash IVF Group Limited (MVF.AX)
Suraksha Diagnostic Limited (SURAKSHA.BO)
Business: Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	94.41	109.76	129.68	152.22	170.45	196.02	240.11	224.28	235.79	250.89
Basic EPS, GAAP	15.25	20.48	21	24.06	25.36	35.97	41.87	27.91	24.95	28.9
Free Cash Flow per Basic Share	14.83	17.16	16.93	13.3	34.21	43.37	43.52	37.98	39.11	- -
Dividend per Share	16.46	0.06	10.63	13.33	7.99	8.03	8	8	4	- -
Book Value per Share	40.51	49.68	67.46	61.76	76.02	102.43	135.34	154.82	175.38	2
Tangible Book Value per Share	51.2	49.76	67.3	63.7	80.99	114.57	14.11	31.48	50.42	68.42
Basic Weighted Avg Shares	50	50	50	50	50	51	51	51	51	51
Sales/Revenue/Turnover	4,755	5,447	6,436	7,601	8,558	9,978	12,283	11,482	12,077	12,853
Operating Margin (%)	23.71	25.46	25.77	24.59	20.72	24.7	23.51	18.19	16.84	17.51
Depreciation Expense	166	172	190	201	393	459	632	892	945	1,038
Net Income, GAAP	768	1,017	1,042	1,201	1,273	1,831	2,142	1,429	1,278	1,480
Effective Tax Rate (%)	35.73	32.93	31.67	33.74	24.41	24.96	26.82	23.52	26.47	25.64
Profit Margin (%)	16.15	18.66	16.2	15.81	14.88	18.35	17.44	12.44	10.58	11.52
Working Capital	1,344	1,333	2,097	1,802	2,276	4,045	916	378	700	1,527
LT Debt	5	4	2	- -	458	789	2,413	1,541	1,191	1,089
Total Equity	2,939	3,442	4,291	4,200	5,252	7,081	8,882	9,907	10,993	11,874
Return on Invested Capital (%)	- -	28.66	29.81	29.63	28.1	27.84	20.46	12.64	11.72	12.48
Return on Capital (%)	- -	39.13	31.52	34.55	34.31	34.77	26.71	15.26	13.31	72.67
Return on Common Equity (%)	- -	45.12	35.86	37.36	36.9	40.55	35.29	19.24	15.12	1,444.74

	Mar'24	Jun'25	Sep'25
Total Current Assets	3,158	- -	3,903
Accounts Receivable, Net	1,263	- -	1,342
Cash, Cash Equivalents & STI	1,243	- -	1,908
Inventories	387	- -	371
Total Current Liabilities	2,459	- -	2,376
Payables & Accruals	- -	- -	- -
ST Debt	780	- -	805
Deferred Revenue	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	2,799	3,003	2,855	2,825	11,482
2024	2,771	3,085	2,911	3,310	12,077
2025	3,134	3,498	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	6.53	7.88	6.99	- -	27.91
2024	5.62	6.92	5.3	- -	24.95
2025	7.41	9.08	- -	- -	- -

	Mar'24	Jun'25	Sep'25
ST Debt	780	- -	805
LT Borrowings	- -	- -	- -
LT Finance Leases	1,191	- -	1,089
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	51	- -	51
Market Capitalization	88,315	101,335	112,295

Metropolis Healthcare Limited

Growth Rates

(avg. rate of change)

Company Description

Working Capital

Growth Rates

(avg. rate of change)

Quarterly Dividends Per Share

Year

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Capital Structure